Clinical trial
Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung…
NCT00004930 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004930 |
|---|---|
| Title | Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases |
| Official title | Phase I and Clinical Pharmacologic Study of Inhaled Doxorubicin in Adults With Advanced Solid Tumors Affecting the Lungs |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer, Metastatic Cancer |
| Intervention type | Drug |
| Interventions | doxorubicin hydrochloride |
| Start date | Jul 1, 1999 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: